380bn essential drug market to be released needs to pay attention to follow-up policies

2013-05-13 source: International Finance reported that by 2015, the market scale of essential drugs for primary medical treatment will reach 200 billion yuan, with a compound annual growth rate of 19% compared with that in 2010 The new edition of the catalogue of essential drugs was officially implemented in May For pharmaceutical enterprises, the basic medicine catalogue is as important as the life and death book The list of basic drugs in the new version increased from 307 in 2009 to 520, including 317 chemicals and biological products and 203 Chinese patent medicines According to the requirements, the new version of essential drugs should reach about 50% in the county-level and second level hospitals, and 25% to 30% in the third level hospitals According to this estimate, by 2015, the market scale of essential drugs for primary medical treatment will reach 200 billion yuan, with a compound annual growth rate of 19% compared with 2010 Based on the requirements of the national health work conference in 2013 to clarify the proportion of basic drugs used in level II and level III medical and health institutions, it is expected that the market scale will be further expanded to 380 billion yuan In the face of a base drug market with a scale of hundreds of billions, all kinds of capitals are "eager to try" However, to get a share of these hundreds of billions of markets, it is crucial to focus on the direction of follow-up policies Fu Hongpeng, deputy researcher of the Research Center for health development of the Ministry of health and family planning, revealed in an interview with the media that, starting from the further improvement and promotion of the basic drug system, the main supporting policies include two aspects: on the one hand, the establishment of a stable and smooth compensation mechanism, the core of which is the financial investment; on the other hand, the rationalization of prices, and the issue of medical insurance policy In addition, in order to avoid the decline of the enthusiasm of medical staff after the implementation of the mechanism, it is necessary to formulate corresponding supporting policies to deepen the reform of staffing, personnel and income distribution According to relevant media reports, the relevant departments of the state will launch a series of follow-up policies around the new base drug catalog The specific schedule is as follows: from May to June this year, the relevant departments will launch the national guidelines for the application of essential drugs and the basic drug formulary; in June, the administrative measures for the allocation and use of medical institutions at all levels will be issued, which will basically clarify the "not busy bidding, not busy supplement" of basic drugs in each province by the end of the first half of the year; before August, the purchase price of non-basic drugs will be determined; 9-10 In June, after the supplementary catalogue of each province was determined, the bidding work began and was completed by the end of this year